{"title":"第一人 - Bina Prajapati","authors":"","doi":"10.1242/jcs.262352","DOIUrl":null,"url":null,"abstract":"\n First Person is a series of interviews with the first authors of a selection of papers published in Journal of Cell Science, helping researchers promote themselves alongside their papers. Bina Prajapati is co-first author on ‘ CCG-1423-derived compounds reduce global RNA synthesis and inhibit transcriptional responses’, published in JCS. Bina conducted the research described in this article while a PhD Student in Maria Vartiainen's lab at the Institute of Biotechnology, University of Helsinki. She is now also a lab coordinator at Finnish Genome Editing Centre (FINGEEC) with Topi Tervonen (FINGEEC PI) at the University of Helsinki. Bina is interested in anything and everything related to cellular health, stress response and disease targets.","PeriodicalId":510778,"journal":{"name":"Journal of Cell Science","volume":"20 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"First person – Bina Prajapati\",\"authors\":\"\",\"doi\":\"10.1242/jcs.262352\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n First Person is a series of interviews with the first authors of a selection of papers published in Journal of Cell Science, helping researchers promote themselves alongside their papers. Bina Prajapati is co-first author on ‘ CCG-1423-derived compounds reduce global RNA synthesis and inhibit transcriptional responses’, published in JCS. Bina conducted the research described in this article while a PhD Student in Maria Vartiainen's lab at the Institute of Biotechnology, University of Helsinki. She is now also a lab coordinator at Finnish Genome Editing Centre (FINGEEC) with Topi Tervonen (FINGEEC PI) at the University of Helsinki. Bina is interested in anything and everything related to cellular health, stress response and disease targets.\",\"PeriodicalId\":510778,\"journal\":{\"name\":\"Journal of Cell Science\",\"volume\":\"20 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cell Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1242/jcs.262352\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cell Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1242/jcs.262352","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
First Person 是对《细胞科学杂志》上发表的部分论文的第一作者进行的系列采访,帮助研究人员在发表论文的同时宣传自己。Bina Prajapati是《细胞科学杂志》上发表的 "CCG-1423衍生化合物减少全局RNA合成并抑制转录反应 "一文的共同第一作者。Bina 在赫尔辛基大学生物技术研究所 Maria Vartiainen 实验室攻读博士学位期间开展了本文所述的研究。现在,她还是芬兰基因组编辑中心(FINGEEC)的实验室协调员,与赫尔辛基大学的托皮-特沃宁(FINGEEC PI)一起工作。Bina 对与细胞健康、应激反应和疾病靶点有关的一切都很感兴趣。
First Person is a series of interviews with the first authors of a selection of papers published in Journal of Cell Science, helping researchers promote themselves alongside their papers. Bina Prajapati is co-first author on ‘ CCG-1423-derived compounds reduce global RNA synthesis and inhibit transcriptional responses’, published in JCS. Bina conducted the research described in this article while a PhD Student in Maria Vartiainen's lab at the Institute of Biotechnology, University of Helsinki. She is now also a lab coordinator at Finnish Genome Editing Centre (FINGEEC) with Topi Tervonen (FINGEEC PI) at the University of Helsinki. Bina is interested in anything and everything related to cellular health, stress response and disease targets.